Denver Health and Hospitals Authority has been awarded a firm fixed price delivery order against the FDA's contract vehicle for $205,010. The order is for a survey of non-medical use of prescription drugs to collect data on selected drugs of interest. Performance will take place in Denver, Colorado and be completed by September 1, 2024. No set-aside designation was used for this order. As the prime contractor, Denver Health will provide data collection and analytics services to the Food and Drug...
This is a $1,467,579.00 delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health) on September 20, 2019. The contract is titled "IMPROVING THE QUALITY AND REPRESENTATIVENESS OF THE TREATMENT CENTER PROGRAM DATA" and has a completion date of March 15, 2025. The contract is a Firm Fixed Price type with no set-aside designation. It is issued under the FDA...
This firm fixed-price delivery order was awarded to Denver Health and Hospital Authority, doing business as Denver Health, by the Food and Drug Administration (FDA). The $87,552.08 contract is for Denver Health to provide the RADARS StreetRx dataset and RADARS drug diversion services to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance efforts. This work is being performed under the FDA Prescription Drug Abuse Summary Reports indefinite...
This is a task order awarded to the Denver Health and Hospital Authority, doing business as Denver Health, by the Food and Drug Administration (FDA). The task order is titled "Data Resource for Post-Marketing Prescription and Over-the-Counter Drug Abuse Surveillance Data from Individuals Entering or Being Assessed for Substance Abuse Treatment Summary Reports." The contract is a firm fixed price delivery order under the FDA Prescription Drug Abuse Summary Reports contract vehicle, with...
The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded a $249,998 firm fixed price purchase order to Denver Health And Hospitals Authority, doing business as Denver Health, for the Psychedelic Online Motivations & Contextual Use Survey. Under this contract, Denver Health will deliver a survey to collect information relating to motivations and contextual use of psychedelic substances. The contract was awarded through open market...
This is a federal contract award from the Department of Health and Human Services Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a state government entity. The contract, with a potential value of $3,293,273.69, is for the COLORADO CTP INSPECTION PROGRAM and has a completion date of September 29, 2020. It is a definitive contract with a cost no fee pricing type, and there is no set-aside designation. The CDPHE, as a subrecipient, has also...
The U.S. Food and Drug Administration (FDA) awarded a Definitive Contract to the Colorado Department of Public Health & Environment (CDPHE) for a Firm Fixed Price contract for "CO HUMAN FOOD CONTRACT" with a total ceiling value of $1,413,010.43. The contract has an ultimate completion date of December 31, 2026. CDPHE is the state public health agency for Colorado and has a significant history of federal contract and grant awards, including work for agencies like the Centers for...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Denver Health and Hospital Authority, doing business as Denver Health, to provide tuberculosis trials and consortium services over a 10-year period. The contract has a ceiling value of $3,780,225.28 and was awarded on January 1, 2021, with an ultimate completion date of December 31, 2030. The contract requires Denver Health to participate in clinical research studies on the treatment,...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver, a major public research university, to conduct a comparison of immunological responses. The $75,000.00 firm fixed-price purchase order has a completion date of May 31, 2017 and was awarded on August 4, 2016 without any set-aside designation. The University of Colorado-Denver holds other federal contracts and grants, including an Indefinite Delivery Contract with...
This is a $100,000.00 firm fixed price contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Clinicahealth, Inc. The contract is for "SOCIAL LISTENING AND PULMONARY ARTERIAL HYPERTENSION" and was awarded on September 14, 2017 with a completion date of July 31, 2018. The work is to be performed in Arlington, Virginia. The contract has no set-aside designation. Clinicahealth, Inc. is a for-profit...